Loyola University Chicago

Running trials

• Recruiting

  Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma

  NCT07236502· Source

• Recruiting

  RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

  NCT06455085· Source

• Recruiting

  The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  NCT05836987· Phase 3· Source

• Active, not recruiting

  Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

  NCT05317416· Phase 3· Source

• Recruiting

  Terumo Aortic Global Endovascular Registry

  NCT04246463· Source

• Active, not recruiting

  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

  NCT03417388· Phase 4· Source

• Active, not recruiting

  Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

  NCT02489539· Source

• Active, not recruiting

  ADAPT - A Patient Registry of the Real-world Use of Orenitram®

  NCT03045029· Source

• Active, not recruiting

  Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

  NCT01586910· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Aortic aneurysm1 recruiting
• Atrial fibrillation1 recruiting
• Multiple myeloma1 recruiting
• Osteoporosis1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

  NCT05776225· Source

• Completed

  Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

  NCT05185089· Phase 2· Source

• Completed

  MIND: Artemis in the Removal of Intracerebral Hemorrhage

  NCT03342664· Source

• Completed

  Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer

  NCT02977468· Phase 1· Source

• Completed

  The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

  NCT01566695· Phase 3· Source

• Completed

  Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

  NCT01757535· Phase 3· Source

Trial sites

• Loyola University Chicago5 trials
• Loyola University of Chicago (Loyola)1 trial
• Loyola University Chicago8 trials
• Loyola University of Chicago1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Dilated cardiomyopathy10 works · 0 trials
• Hidradenitis suppurativa7 works · 0 trials
• Tourette syndrome3 works · 0 trials
• Polycystic kidney disease3 works · 0 trials